Literature DB >> 23897599

[Obesity and cardiac cachexia in chronic heart failure].

M Clauser1, J Altenberger.   

Abstract

Obesity as well as cardiac cachexia in heart failure patients are not fully understood and therefore of high scientific interest. Obesity as a common risk factor for cardiovascular disease is associated with a high mortality. In contrast obesity in patients suffering from chronic heart failure seems to be accompanied with a favorable outcome in contrast to people with normal weight, known as the obesity paradox. In the last decade there has been growing interest in cachexia, which is common in advanced stages of chronic diseases, such as heart failure, chronic obstructive pulmonary disease (COPD), cancer and renal failure and is associated with a poor prognosis. Until now cachexia has been underdiagnosed and undertreated. This review discusses the complex underlying pathomechanisms as well as potential therapeutic approaches.

Entities:  

Mesh:

Year:  2013        PMID: 23897599     DOI: 10.1007/s00059-013-3885-0

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  100 in total

1.  The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis.

Authors:  Kamyar Kalantar-Zadeh; Elani Streja; Csaba P Kovesdy; Antigone Oreopoulos; Nazanin Noori; Jennie Jing; Allen R Nissenson; Mahesh Krishnan; Joel D Kopple; Rajnish Mehrotra; Stefan D Anker
Journal:  Mayo Clin Proc       Date:  2010-11       Impact factor: 7.616

2.  Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia.

Authors:  W Doehner; C D Pflaum; M Rauchhaus; I F Godsland; K Egerer; M Cicoira; V G Florea; R Sharma; A P Bolger; A J Coats; S D Anker; C J Strasburger
Journal:  Eur J Endocrinol       Date:  2001-12       Impact factor: 6.664

3.  Childhood obesity, other cardiovascular risk factors, and premature death.

Authors:  Paul W Franks; Robert L Hanson; William C Knowler; Maurice L Sievers; Peter H Bennett; Helen C Looker
Journal:  N Engl J Med       Date:  2010-02-11       Impact factor: 91.245

4.  Expression of ob gene in adipose cells. Regulation by insulin.

Authors:  P Leroy; S Dessolin; P Villageois; B C Moon; J M Friedman; G Ailhaud; C Dani
Journal:  J Biol Chem       Date:  1996-02-02       Impact factor: 5.157

5.  Ghrelin induces adiposity in rodents.

Authors:  M Tschöp; D L Smiley; M L Heiman
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

6.  Cachexia as a major underestimated and unmet medical need: facts and numbers.

Authors:  Stephan von Haehling; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2010-10-26       Impact factor: 12.910

7.  Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure.

Authors:  Joerg Heineke; Mannix Auger-Messier; Jian Xu; Michelle Sargent; Allen York; Stephen Welle; Jeffery D Molkentin
Journal:  Circulation       Date:  2010-01-11       Impact factor: 29.690

8.  Ghrelin for cachexia.

Authors:  Takashi Akamizu; Kenji Kangawa
Journal:  J Cachexia Sarcopenia Muscle       Date:  2010-12-17       Impact factor: 12.910

9.  The obesity paradox in chronic disease: facts and numbers.

Authors:  Mitja Lainscak; Stephan von Haehling; Wolfram Doehner; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-03-14       Impact factor: 12.910

10.  Endotoxin binding by sevelamer: potential impact on nutritional status.

Authors:  Natsuki Kubotera; Alexander J Prokopienko; Adinoyi O Garba; Amy Barton Pai
Journal:  Int J Nephrol       Date:  2013-01-17
View more
  1 in total

Review 1.  Unraveling the Role of Epicardial Adipose Tissue in Coronary Artery Disease: Partners in Crime?

Authors:  Glória Conceição; Diana Martins; Isabel M Miranda; Adelino F Leite-Moreira; Rui Vitorino; Inês Falcão-Pires
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.